Telo Genomics (TELO.V) Stock Price

Telo Genomics Price

TSX·CLOSED
0.05CAD+0.00 (+0.00 %)
Market closed

Over the past year Telo Genomics shares have lost 40.0%. The stock trades about 13% above its 52-week low.

Telo Genomics stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Telo Genomics over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Telo Genomics stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Telo Genomics's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Telo Genomics Stock Price History
DateTelo Genomics Price
8/12/20260.05 CAD
8/11/20260.05 CAD
8/10/20260.05 CAD
8/7/20260.05 CAD
8/6/20260.05 CAD
8/5/20260.05 CAD
8/4/20260.05 CAD
7/30/20260.05 CAD
7/29/20260.05 CAD
7/28/20260.04 CAD
7/27/20260.04 CAD
7/24/20260.04 CAD
7/23/20260.04 CAD
7/22/20260.05 CAD
7/21/20260.05 CAD
7/20/20260.05 CAD
7/17/20260.05 CAD
7/16/20260.05 CAD
7/15/20260.05 CAD
7/14/20260.05 CAD
7/13/20260.05 CAD
7/10/20260.05 CAD
7/9/20260.05 CAD
7/8/20260.04 CAD
7/7/20260.04 CAD
7/6/20260.05 CAD
7/3/20260.05 CAD
7/2/20260.05 CAD
6/30/20260.04 CAD
6/29/20260.04 CAD
6/26/20260.04 CAD
6/25/20260.05 CAD
6/24/20260.05 CAD
6/23/20260.05 CAD
6/22/20260.05 CAD
6/19/20260.05 CAD
6/18/20260.05 CAD
6/17/20260.05 CAD
6/16/20260.05 CAD
6/15/20260.06 CAD
6/12/20260.06 CAD
6/11/20260.06 CAD
6/10/20260.06 CAD
6/9/20260.06 CAD
6/8/20260.05 CAD
6/5/20260.05 CAD
6/4/20260.06 CAD
6/3/20260.06 CAD
6/2/20260.06 CAD
6/1/20260.06 CAD
5/29/20260.06 CAD
5/28/20260.06 CAD
5/27/20260.06 CAD
5/26/20260.06 CAD
5/25/20260.06 CAD
5/22/20260.06 CAD
5/21/20260.05 CAD
5/20/20260.05 CAD
5/19/20260.05 CAD
5/15/20260.05 CAD
5/14/20260.06 CAD
5/13/20260.05 CAD
5/12/20260.06 CAD
5/11/20260.06 CAD
5/8/20260.06 CAD
5/7/20260.06 CAD
5/6/20260.05 CAD
5/5/20260.05 CAD
5/4/20260.05 CAD
5/1/20260.05 CAD
4/30/20260.05 CAD
4/29/20260.05 CAD
4/28/20260.05 CAD
4/27/20260.05 CAD
4/24/20260.05 CAD
4/23/20260.05 CAD
4/22/20260.05 CAD
4/21/20260.05 CAD
4/20/20260.05 CAD
4/17/20260.06 CAD
4/16/20260.06 CAD
4/15/20260.05 CAD
4/14/20260.05 CAD
4/13/20260.05 CAD
4/10/20260.06 CAD
4/9/20260.06 CAD
4/8/20260.06 CAD
4/7/20260.06 CAD
4/6/20260.06 CAD
4/2/20260.05 CAD
4/1/20260.05 CAD
3/31/20260.05 CAD
3/30/20260.05 CAD
3/27/20260.05 CAD
3/26/20260.05 CAD
3/25/20260.05 CAD
3/24/20260.05 CAD
3/23/20260.05 CAD
3/20/20260.05 CAD
3/19/20260.05 CAD
3/18/20260.05 CAD
3/17/20260.05 CAD
3/16/20260.05 CAD
3/13/20260.05 CAD
3/12/20260.05 CAD
3/11/20260.05 CAD
3/10/20260.05 CAD
3/9/20260.05 CAD
3/6/20260.05 CAD
3/5/20260.05 CAD
3/4/20260.05 CAD
3/3/20260.05 CAD
3/2/20260.05 CAD
2/27/20260.05 CAD
2/26/20260.05 CAD
2/25/20260.05 CAD
2/24/20260.05 CAD
2/23/20260.05 CAD
2/20/20260.05 CAD
2/19/20260.05 CAD
2/18/20260.05 CAD
2/17/20260.05 CAD
2/13/20260.05 CAD
2/12/20260.05 CAD
2/11/20260.04 CAD
2/10/20260.04 CAD
2/9/20260.04 CAD
2/6/20260.05 CAD
2/5/20260.05 CAD
2/4/20260.04 CAD
2/3/20260.04 CAD
2/2/20260.05 CAD
1/30/20260.05 CAD
1/29/20260.05 CAD
1/28/20260.05 CAD
1/27/20260.05 CAD
1/26/20260.05 CAD
1/23/20260.05 CAD
1/22/20260.05 CAD
1/21/20260.05 CAD
1/20/20260.05 CAD
1/19/20260.05 CAD
1/16/20260.05 CAD
1/15/20260.05 CAD
1/14/20260.05 CAD
1/13/20260.05 CAD
1/12/20260.05 CAD
1/9/20260.05 CAD
1/8/20260.05 CAD
1/7/20260.05 CAD
1/6/20260.05 CAD
1/5/20260.05 CAD
1/2/20260.05 CAD
12/31/20250.05 CAD
12/30/20250.05 CAD
12/29/20250.05 CAD
12/24/20250.05 CAD
12/23/20250.05 CAD
12/22/20250.05 CAD
12/19/20250.05 CAD
12/18/20250.05 CAD
12/17/20250.05 CAD
12/16/20250.05 CAD
12/15/20250.05 CAD
12/12/20250.05 CAD
12/11/20250.05 CAD
12/10/20250.05 CAD
12/9/20250.05 CAD
12/8/20250.05 CAD
12/5/20250.05 CAD
12/4/20250.05 CAD
12/3/20250.05 CAD
12/2/20250.05 CAD
12/1/20250.05 CAD
11/28/20250.05 CAD
11/27/20250.05 CAD
11/26/20250.05 CAD
11/25/20250.05 CAD
11/24/20250.05 CAD
11/21/20250.05 CAD
11/20/20250.06 CAD
11/19/20250.07 CAD
11/18/20250.07 CAD
11/17/20250.08 CAD
11/14/20250.08 CAD
11/13/20250.06 CAD
11/12/20250.05 CAD
11/11/20250.05 CAD
11/10/20250.06 CAD
11/7/20250.06 CAD
11/6/20250.06 CAD
11/5/20250.05 CAD
11/4/20250.05 CAD
11/3/20250.05 CAD
10/31/20250.05 CAD
10/30/20250.05 CAD
10/29/20250.05 CAD
10/28/20250.05 CAD
10/27/20250.05 CAD
10/24/20250.06 CAD
10/23/20250.07 CAD
10/22/20250.07 CAD
10/21/20250.07 CAD
10/20/20250.07 CAD
10/17/20250.06 CAD
10/16/20250.06 CAD
10/15/20250.06 CAD
10/14/20250.06 CAD
10/10/20250.06 CAD
10/9/20250.06 CAD
10/8/20250.06 CAD
10/7/20250.06 CAD
10/6/20250.07 CAD
10/3/20250.07 CAD
10/2/20250.07 CAD
10/1/20250.07 CAD
9/30/20250.06 CAD
9/29/20250.06 CAD
9/26/20250.08 CAD
9/25/20250.08 CAD
9/24/20250.08 CAD
9/23/20250.08 CAD
9/22/20250.08 CAD
9/19/20250.08 CAD
9/18/20250.07 CAD
9/17/20250.07 CAD
9/16/20250.08 CAD
9/15/20250.07 CAD
9/12/20250.07 CAD
9/11/20250.08 CAD
9/10/20250.08 CAD
9/9/20250.08 CAD
9/8/20250.08 CAD
9/5/20250.08 CAD
9/4/20250.08 CAD
9/3/20250.07 CAD
9/2/20250.08 CAD
8/29/20250.08 CAD
8/28/20250.07 CAD
8/27/20250.07 CAD
8/26/20250.08 CAD
8/25/20250.08 CAD
8/22/20250.07 CAD
8/21/20250.08 CAD
8/20/20250.08 CAD
8/19/20250.08 CAD
8/18/20250.08 CAD
8/15/20250.07 CAD
8/14/20250.08 CAD
Access this data via the Eulerpool API
Get Free API Key

Telo Genomics Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
0.00 CAD
-4.61 M CAD
-4.69 M CAD
Jan 1, 2019
0.00 CAD
-1.05 M CAD
-1.07 M CAD
Jan 1, 2020
0.00 CAD
-1.31 M CAD
-1.24 M CAD
Jan 1, 2021
0.00 CAD
-1.26 M CAD
-1.07 M CAD
Jan 1, 2022
0.00 CAD
-2.11 M CAD
-2.11 M CAD
Jan 1, 2023
0.00 CAD
-2.82 M CAD
-2.82 M CAD
Jan 1, 2024
0.00 CAD
-2.72 M CAD
-2.71 M CAD
Jan 1, 2025
0.00 CAD
-2.70 M CAD
-2.72 M CAD

Telo Genomics Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 14, 2026, 12:30 PM
 
EBITM CAD
NET INCOMEM CAD
NET INCOME GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
––––––-1.00-9.00-4.00-1.00-1.00-1.00-2.00-2.00-2.00-2.00
––––––-1.00-9.00-4.00-1.00-1.00-1.00-2.00-2.00-2.00-2.00
–––––––800.00-55.56-75.00––100.00–––
0.850.850.790.850.840.881.189.5411.9513.2329.9346.8958.6660.1571.3887.74
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Telo Genomics generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Telo Genomics retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Telo Genomics's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Telo Genomics has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Telo Genomics's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Telo Genomics stock margins

The Telo Genomics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Telo Genomics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Telo Genomics.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
0.00 %
- %
- %
Jan 1, 2019
0.00 %
- %
- %
Jan 1, 2020
0.00 %
- %
- %
Jan 1, 2021
0.00 %
- %
- %
Jan 1, 2022
0.00 %
- %
- %
Jan 1, 2023
0.00 %
- %
- %
Jan 1, 2024
0.00 %
- %
- %
Jan 1, 2025
0.00 %
- %
- %

Telo Genomics Stock Revenue, EBIT, Earnings per Share

The Telo Genomics earnings per share therefore indicates how much revenue Telo Genomics has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.00 CAD
-0.39 CAD
-0.39 CAD
Jan 1, 2019
0.00 CAD
-0.08 CAD
-0.08 CAD
Jan 1, 2020
0.00 CAD
-0.04 CAD
-0.04 CAD
Jan 1, 2021
0.00 CAD
-0.03 CAD
-0.02 CAD
Jan 1, 2022
0.00 CAD
-0.04 CAD
-0.04 CAD
Jan 1, 2023
0.00 CAD
-0.05 CAD
-0.05 CAD
Jan 1, 2024
0.00 CAD
-0.04 CAD
-0.04 CAD
Jan 1, 2025
0.00 CAD
-0.03 CAD
-0.03 CAD

Telo Genomics business model & stock analysis

Telo Genomics Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Telo Genomics historical P/E ratio, EBIT multiple, and P/S ratio

Telo Genomics annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Telo Genomics shares outstanding

The number of shares of Telo Genomics was 87.74 M in 2025. This indicates how many shares Telo Genomics is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
11.95 M Stocks
Jan 1, 2019
13.23 M Stocks
Jan 1, 2020
29.93 M Stocks
Jan 1, 2021
46.89 M Stocks
Jan 1, 2022
58.66 M Stocks
Jan 1, 2023
60.15 M Stocks
Jan 1, 2024
71.38 M Stocks
Jan 1, 2025
87.74 M Stocks

Telo Genomics stock splits

In Telo Genomics's history, there have been no stock splits.
Price targets and forecasts for Telo Genomics are not yet available.

Telo Genomics shareholder structure

% Name
0.33854%
CATAM Asset Management AG
CATAM Asset Management AG

Telo Genomics Executives and Management Board

6 members · avg. age 56 · 17 % women

CR

Mr. Christopher Ross (53)

Chief Financial Officer

60,000.00 CAD

Management

SM

Dr. Sabine Mai

Interim Chief Executive Officer, Director, Chair of the Clinical and Scientific Advisory Board · since 2016

30,000.00 CAD

Board of Directors

GB

Mr. Guido Baechler (59)

Executive Chairman of the Board · since 2019

81,667.00 CAD
RM

Dr. Ron Mcglennen

Independent Director

40,833.00 CAD
JM

Mr. John Meekison

Independent Director

18,000.00 CAD
JF

Mr. John Farlinger

Director

–

Frequently asked questions about Telo Genomics

Converted at the current exchange rate, the Telo Genomics share trades at 0.03 EUR (0.05 CAD).

The Telo Genomics share (TELO.V) is listed on 4 stock exchanges, including: Frankfurt (3D0A.F), München (3D0A.MU), Toronto (TELO.V).

No history available for Telo Genomics.

The revenue cannot currently be calculated for Telo Genomics.

The profit cannot currently be calculated for Telo Genomics.

The P/E ratio cannot be calculated for Telo Genomics at the moment.

The P/S cannot be calculated for Telo Genomics currently.

The Eulerpool Quality Score for Telo Genomics is 2/10.

The ISIN of Telo Genomics is CA87975M2085. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Telo Genomics is A2PV0Q. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Telo Genomics is TELO.V. The ticker symbol is used to trade Telo Genomics shares on the stock exchange.

Telo Genomics paid dividends every year for the past 0 years.

Telo Genomics is assigned to the 'Health' sector.

The dividends of Telo Genomics are distributed in CAD.

All fundamentals and in-depth analysis of Telo Genomics

Our stock analysis for Telo Genomics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Telo Genomics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Telo Genomics Stock
Telo Genomics Revenue→
Telo Genomics Stock
Telo Genomics Net Income→
Telo Genomics Stock
Telo Genomics P/E→
Telo Genomics Stock
Telo Genomics P/S→
Telo Genomics Stock
Telo Genomics EBIT→
Telo Genomics Stock
Telo Genomics Dividend→
Telo Genomics Stock
Telo Genomics Directors Dealings→
Telo Genomics Stock
Telo Genomics Stocks→
Telo Genomics Stock
Telo Genomics Market capitalization→
Telo Genomics Stock
Telo Genomics Debt→
Telo Genomics Stock
Telo Genomics Liabilities→
Telo Genomics Stock
Telo Genomics Equity→
Telo Genomics Stock
Telo Genomics AAQS→
Telo Genomics Stock
Telo Genomics Employees→
Telo Genomics Stock
Telo Genomics ROE→
Telo Genomics Stock
Telo Genomics ROA→
Telo Genomics Stock
Telo Genomics ROCE→
Telo Genomics Stock
Telo Genomics News→
Telo Genomics Stock
Telo Genomics Analyst Price Targets→

Health Stocks

Telomir PharmaceuticalsTellgenTempest TherapeuticsTelix Pharmaceuticals LimitedTempo Scan Pacific Tbk PTTeleflexTempus AITeladoc HealthTenax TherapeuticsTELA BioTenaya TherapeuticsTejnaksh HealthcareAll Stocks A–Z →